NetraMark Holdings Inc. (TSX:AIAI)
Canada · Delayed Price · Currency is CAD 0.9500
+0.0300 (3.26%)
Apr 21, 2026, 2:32 PM EDT
NetraMark Holdings Revenue
NetraMark Holdings had revenue of 118.85K CAD in the quarter ending December 31, 2025, a decrease of -69.22%. This brings the company's revenue in the last twelve months to 165.26K, down -80.37% year-over-year. In the fiscal year ending September 30, 2025, NetraMark Holdings had annual revenue of 432.50K, down -5.18%.
Revenue (ttm)
165.26K
Revenue Growth
-80.37%
P/S Ratio
532.58
Revenue / Employee
n/a
Employees
n/a
Market Cap
88.02M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 432.50K | -23.63K | -5.18% |
| Sep 30, 2024 | 456.13K | 366.86K | 410.97% |
| Sep 30, 2023 | 89.27K | -23.76K | -21.02% |
| Sep 30, 2022 | 113.03K | - | - |
| Sep 30, 2021 | - | - | - |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vitalhub | 108.97M |
| kneat.com | 63.26M |
| Hydreight Technologies | 24.48M |
| NexgenRx | 17.93M |
| Comprehensive Healthcare Systems | 5.79M |
| Principal Technologies | 370.42K |
| AI/ML Innovations | 125.47K |
| DIAGNOS | 68.16K |
NetraMark Holdings News
- 9 hours ago - NetraMark Positioned to Advance Psychedelic Clinical Trials Following U.S. Executive Order, Supported by Peer-Reviewed Research and Active Programs - GlobeNewsWire
- 2 days ago - Netramark Comments on U.S. Executive Order to Accelerate Treatments for Serious Mental Illness and Highlights the Need for Regulatory‑Grade Trial Design in Psychedelic Development - GlobeNewsWire
- 13 days ago - Netramark-Authored, Peer-Reviewed Article Suggests Psychedelics Might Not Only Affect Brain Chemistry, They May Also Involve Quantum-Level Processes Inside the Brain - GlobeNewsWire
- 4 weeks ago - NetraMark Announces Strategic Oncology Research Collaboration with Fondazione per la Medicina Personalizzata to Analyze Landmark ROME Trial Dataset - GlobeNewsWire
- 4 weeks ago - NetraMark Unveils AI-Discovered Treatment-Responsive Subgroups in A4 Alzheimer's Trial at AD/PD Conference - GlobeNewsWire
- 6 weeks ago - NetraMark Signs Contract With Global Biopharmaceutical Company to Analyze Phase 2 Depression Trial Data - GlobeNewsWire
- 2 months ago - NetraMark Closes Final Tranche of $3.5 Million Private Placement - GlobeNewsWire
- 2 months ago - CSE Bulletin: Delist - NetraMark Holdings Inc. (AIAI) - Newsfile Corp